The Personalized Biotech Flywheel Cathie Wood Built Is Still a Winning Bet Today [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
CRISPR Therapeutics CRSP ) saw CASGEVY generate $116M in 2025 revenue with 147 patients in treatment and pediatric submissions planned for H1 2026. Cathie Wood's ARK Genomic Revolution ETF holds CRSP at 9.29% and ILMN at 4.44%, treating both as essential infrastructure for personalized medicine. The precision medicine market is forecast to grow 16.3% annually to $249.24B by 2030, creating a natural flywheel where Illumina's sequencing data enables CRISPR's more precise gene edits, which validate the need for deeper genomic profiling. A recent study identified one single habit that doubled Americans' retirement savings and moved retirement from dream, to reality. Read more here What if the biggest winners in biotech weren't the ones promising miracle cures, but the ones quietly supplying the picks and shovels -- data that makes those cures possible? The personalized biotech revolution turns raw genetic information into tailored treatments that actually work for each patient. Gr
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- The cutting-edge treatment that could lower dangerously high cholesterol [MSNBC.com]MSNBC.com
- A one-time treatment tweaked their genes — and lowered their cholesterol [MSNBC.com]MSNBC.com
- Assessing CRISPR Therapeutics (CRSP) Valuation As Recent Returns Send Mixed Signals [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts [Yahoo! Finance]Yahoo! Finance
- I Expect Crispr Therapeutics To Break Out As 2026 Revenue Exceeds Expectations [Seeking Alpha]Seeking Alpha
CRSP
Earnings
- 2/12/26 - Miss
CRSP
Sec Filings
- 4/2/26 - Form PRE
- 3/24/26 - Form 4
- 3/24/26 - Form 4
- CRSP's page on the SEC website